|
Mutation Information
|
Mutation Site
|
E157Q |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
IN |
|
Country
|
France |
Literature Information
|
PubMed PMID
|
33693680
|
|
Clinical information
|
Yes
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2021 |
|
Journal
|
The Journal of antimicrobial chemotherapy |
|
Title
|
No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments. |
|
Author
|
Abdi B,Chebbi M,Wirden M,Teyssou E,Sayon S,Palich R,Seang S,Valantin MA,Simon A,Tubiana R,Katlama C,Calvez V,Marcelin AG,Soulie C |
|
Evidence
|
The HIV-1 integrase sequences from CSF presented resistance mutations for 9/27 (33.3%) and 8/32 (25.0%) for ARV-naive (L74I, n = 3; L74I/M, n = 1; T97A, n = 1; E157Q, n = 4) and ARV-treated (L74I, n = 6; L74M, n = 1; T97A, n = 1; N155H, n = 1) patients, respectively.
|
|
|
HIV Mutation Detail Information